Annovis Bio Inc reports results for the quarter ended in March - Earnings Summary

Annovis Bio

11/05/2023 21:13

* Annovis Bio Inc  ANVS.N  reported a quarterly adjusted
loss of
$1.19​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 33
cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Annovis Bio Inc's reported EPS for the quarter was a loss
of
$1.19​.
    * The mean earnings estimate of analysts had risen by
about 62.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Annovis Bio Inc shares had fallen by 2.9% this quarter and
gained 11.4% so far this year.
    * The company reported a quarterly loss of $9.74 million.
    * Wall Street's median 12-month price target for Annovis Bio
Inc
is $40.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 08:13 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.33          -1.19          Missed
 Dec. 31 2022      -1.05          -0.38          Beat
 Sep. 30 2022      -1.01          -0.93          Beat
 Jun. 30 2022      -0.64          -1.07          Missed